Quote For Arena Pharmaceuticals Inc ARNA.O
sector: Healthcare ·
industry: Biotechnology ·
$3.67
1 Dec 2009
+1.10%
$3.63
$3.66
2,080,109
$3.77
$3.58
$7.42
$2.26
0.70
1,458,809
News
Press Releases
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Lief, Jack |
Chairman of the Board, President, Chief Executive Officer |
2,140,150 |
| Hoffman, Robert |
Chief Financial Officer, Vice President - Finance |
731,977 |
| Spector, Steven |
Senior Vice President, General Counsel, Secretary |
917,068 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$336.57 |
| Shares Outstanding (Mil.) |
92.72 |
| Float (Mil.) |
91.13 |
| |
| Dividend Information |
| Yield % |
-99,999.99 |
| Annual Dividend ($ USD) |
0.00 |
| Payout Ratio(TTM) % |
-- |
| |
| Financial Strength |
| Quick Ratio |
2.48 |
| Current Ratio |
6.91 |
| LT Debt/Equity |
126.70 |
| Total Debt/Equity |
127.34 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
-- |
| Price/Sales(TTM) |
32.35 |
| Price/Book(TTM) |
3.28 |
| Price/Cash Flow(TTM) |
-- |
| |
|
| Per Share Data |
| Earnings(TTM) |
$-2.39 |
| Sales(TTM) |
$0.13 |
| Book Value(MRQ) |
$1.11 |
| Cash Flow(TTM) |
$-2.16 |
| Cash(MRQ) |
$1.55 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
-133.21 |
| Return on Assets(TTM) |
-61.12 |
| Return on Investment(TTM) |
-67.08 |
| |
|
| Margins |
| Gross Margin(TTM) % |
34.11 |
| Operating Margin(TTM) % |
-1,674.13 |
| Profit Margin(TTM) % |
-1,784.53 |
|
| |
|
UK
US
- Europe
- Asia
- UK Most Actives